Inge S van Loenen1, Sophie J M Rijnen2, Jimme Bruijn3, Geert-Jan M Rutten4, Karin Gehring3, Margriet M Sitskoorn1. 1. Department of Cognitive Neuropsychology, Tilburg University, Tilburg, The Netherlands. 2. Department of Cognitive Neuropsychology, Tilburg University, Tilburg, The Netherlands; Department of Neurosurgery, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands. Electronic address: s.j.m.rijnen@uvt.nl. 3. Department of Cognitive Neuropsychology, Tilburg University, Tilburg, The Netherlands; Department of Neurosurgery, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands. 4. Department of Neurosurgery, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands.
Abstract
BACKGROUND: There is a growing interest to include evaluations of cognitive performance in the clinical management of patients with glioblastoma (GBM). However, as changes in cognitive performance of a group may mask changes in individual patients, study results are often difficult to transfer into clinical practice. We focused on the comparison of group versus individual changes in neuropsychological performance of patients with GBM after initial surgical treatment. METHODS: Patients underwent neuropsychological evaluation using CNS Vital Signs 1 day prior to and 3 months after surgery. Two-tailed paired-samples t tests were conducted to assess changes on the group level. Reliable change indices (RCIs) that correct for practice effects and imperfect test-retest reliabilities were used to examine changes in individual patients. RESULTS: Cognitive dysfunction was common (>80%) both before and 3 months after surgery in this sample of 82 patients with GBM. Whereas group analyses revealed minimal changes in performance over time, RCIs demonstrated that most patients (89%) showed changes in performance in at least 1 cognitive domain. Half of these individual patients solely showed improvements, a quarter solely showed declines, and another quarter showed both improvements and declines. CONCLUSIONS: This study clearly demonstrates that important individual changes in performance are masked when looking only at group results. Future studies should more often use an individual patient approach to enhance knowledge transfer into clinical practice.
BACKGROUND: There is a growing interest to include evaluations of cognitive performance in the clinical management of patients with glioblastoma (GBM). However, as changes in cognitive performance of a group may mask changes in individual patients, study results are often difficult to transfer into clinical practice. We focused on the comparison of group versus individual changes in neuropsychological performance of patients with GBM after initial surgical treatment. METHODS:Patients underwent neuropsychological evaluation using CNS Vital Signs 1 day prior to and 3 months after surgery. Two-tailed paired-samples t tests were conducted to assess changes on the group level. Reliable change indices (RCIs) that correct for practice effects and imperfect test-retest reliabilities were used to examine changes in individual patients. RESULTS:Cognitive dysfunction was common (>80%) both before and 3 months after surgery in this sample of 82 patients with GBM. Whereas group analyses revealed minimal changes in performance over time, RCIs demonstrated that most patients (89%) showed changes in performance in at least 1 cognitive domain. Half of these individual patients solely showed improvements, a quarter solely showed declines, and another quarter showed both improvements and declines. CONCLUSIONS: This study clearly demonstrates that important individual changes in performance are masked when looking only at group results. Future studies should more often use an individual patient approach to enhance knowledge transfer into clinical practice.
Authors: Isabel K Gosselt; Vera P M Scheepers; Lauriane A Spreij; Johanna M A Visser-Meily; Tanja C W Nijboer Journal: Neurooncol Pract Date: 2020-11-21
Authors: Sophie J M Rijnen; Elke Butterbrod; Geert-Jan M Rutten; Margriet M Sitskoorn; Karin Gehring Journal: Neurosurgery Date: 2020-11-16 Impact factor: 4.654
Authors: Philip C De Witt Hamer; Philip C De Witt Hamer; Martin Klein; Shawn L Hervey-Jumper; Jeffrey S Wefel; Mitchel S Berger Journal: Neurosurgery Date: 2021-03-15 Impact factor: 4.654
Authors: Linda Dirven; Jammbe Z Musoro; Corneel Coens; Jaap C Reijneveld; Martin J B Taphoorn; Florien W Boele; Mogens Groenvold; Martin J van den Bent; Roger Stupp; Galina Velikova; Kim Cocks; Mirjam A G Sprangers; Madeleine T King; Hans-Henning Flechtner; Andrew Bottomley Journal: Neuro Oncol Date: 2021-08-02 Impact factor: 12.300